Ligand Pharmaceuticals
LGND
LGND
180 hedge funds and large institutions have $1.15B invested in Ligand Pharmaceuticals in 2014 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 65 increasing their positions, 63 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
3% more repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 63
26% less call options, than puts
Call options by funds: $1.82M | Put options by funds: $2.45M
Holders
180
Holding in Top 10
6
Calls
$1.82M
Puts
$2.45M
Top Buyers
| 1 | +$15.6M | |
| 2 | +$15.4M | |
| 3 | +$10.6M | |
| 4 |
William Blair & Company
Chicago,
Illinois
|
+$5.84M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$5.82M |
Top Sellers
| 1 | -$29.1M | |
| 2 | -$24.7M | |
| 3 | -$15.9M | |
| 4 |
BI
BVF Inc
San Francisco,
California
|
-$13.2M |
| 5 |
TCP
TAMRO Capital Partners
Alexandria,
Virginia
|
-$7.18M |